P (NASDAQ:BIB) Files An 8-K Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure.
On January 29, 2021, United States 12 Month Natural Gas Fund, LP (the “Registrant”) issued its monthly account statement for the month ended December 31, 2020, which is presented in the form of a Statement of Income (Loss) and a Statement of Changes in Net Asset Value, as required to Rule 4.22 under the Commodity Exchange Act. A copy of the monthly account statement is furnished as Exhibit 99.1 to this Current Report on Form 8-K and also can be found on the Registrant’s website at www.uscfinvestments.com. The information furnished in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in any such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit 99.1 |
United States 12 Month Natural Gas Fund, LP Exhibit
EX-99.1 2 tm213397d5_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 United States 12 Month Natural Gas Fund,…
To view the full exhibit click here
About P (NASDAQ:BIB)
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in derivatives that have similar daily performance characteristics as the inverse of the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.
